Real-world data on ranibizumab for myopic choroidal neovascularization due to pathologic myopia: results from a post-marketing surveillance in Japan

被引：0
|
作者：
Kyoko Ohno-Matsui
Makoto Suzaki
Rie Teshima
Nina Okami
机构：
[1] Tokyo Medical and Dental University,Department of Ophthalmology and Visual Science
[2] Novartis Pharma K.K.,Medical Scientific Expert, Medical Division
[3] Novartis Pharma K.K.,Biostatistics, Japan Development
[4] Novartis Pharma K.K.,Patient Safety Japan, Regulatory Office Japan
来源：
Eye | 2018年 / 32卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1871 / 1878
页数：7
相关论文
共 50 条
  • [31] Real-World Safety and Effectiveness of Golimumab in Rheumatic Diseases: Post-Marketing Surveillance in Korea
    Kim, Hyeongyeong
    Kim, Youngdoe
    Lee, YoungJa
    RHEUMATOLOGY AND THERAPY, 2021, 8 (03) : 1393 - 1404
  • [32] Real-World Safety and Effectiveness of Golimumab in Rheumatic Diseases: Post-Marketing Surveillance in Korea
    Hyeongyeong Kim
    Youngdoe Kim
    YoungJa Lee
    Rheumatology and Therapy, 2021, 8 : 1393 - 1404
  • [33] Real-World Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Interim Report of a Post-Marketing Surveillance in Japan
    Takashi Ogura
    Yoshikazu Inoue
    Arata Azuma
    Sakae Homma
    Yasuhiro Kondoh
    Katsumi Tanaka
    Kaori Ochiai
    Yukihiko Sugiyama
    Toshihiro Nukiwa
    Advances in Therapy, 2023, 40 (4) : 1474 - 1493
  • [34] Real-World Safety and Effectiveness of Letermovir in Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation: Final Results of Post-Marketing Surveillance in Japan
    Fukuda, Masaki
    Hattori, Junko
    Ohkubo, Rika
    Watanabe, Asuka
    Maekawa, Shinichiroh
    CLINICAL DRUG INVESTIGATION, 2024, 44 (07) : 527 - 540
  • [35] A post-marketing surveillance of the real-world safety and effectiveness of avelumab in patients with curatively unresectable Merkel cell carcinoma in Japan
    Yamazaki, N.
    Kiyohara, Y.
    Sato, M.
    Endo, S.
    Song, B.
    Tanaka, Y.
    Kambe, A.
    Sato, Y.
    Uhara, H.
    ANNALS OF ONCOLOGY, 2022, 33 : S1601 - S1602
  • [36] Real-world outcomes of pembrolizumab monotherapy in non-small cell lung cancer in Japan: A post-marketing surveillance
    Yamamoto, Nobuyuki
    Kamitani, Tetsu
    Kanda, Kingo
    Ito, Yuichiro
    Hamada, Masahiro
    Ozaki, Masahiko
    Takeuchi, Noriko
    Yamada, Tomoko
    Kawano, Masaki
    Maekawa, Shinichiroh
    Kato, Terufumi
    CANCER SCIENCE, 2022, 113 (09) : 3110 - 3119
  • [37] Real-world safety and effectiveness of rotigotine in patients with Parkinson's disease: analysis of a post-marketing surveillance study in Japan
    Ito, Hidefumi
    Takayama, Tomoyo
    Kondo, Hiroyuki
    Fukuta, Yasuhiko
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2022, 132 (03) : 237 - 247
  • [38] Safety and effectiveness of everolimus in maintenance kidney transplant patients in the real-world setting: results from a 2-year post-marketing surveillance study in Japan
    Hayase, Naomi
    Yamada, Mariko
    Kaneko, Shuhei
    Watanabe, Yoko
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2021, 25 (06) : 660 - 673
  • [39] Real-World Safety and Tolerability of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Interim Report of a Post-Marketing Surveillance in Japan
    Ogura, Takashi
    Inoue, Yoshikazu
    Azuma, Arata
    Homma, Sakae
    Kondoh, Yasuhiro
    Tanaka, Katsumi
    Ochiai, Kaori
    Sugiyama, Yukihiko
    Nukiwa, Toshihiro
    ADVANCES IN THERAPY, 2023, 40 (04) : 1474 - 1493
  • [40] Real-world assessment of onasemnogene abeparvovec treatment in patients with spinal muscular atrophy: RESTORE/post-marketing surveillance in Japan
    Saito, K.
    Nagao, R.
    Tsuchida, K.
    Teshima, R.
    Kawase, K.
    NEUROMUSCULAR DISORDERS, 2022, 32 : S92 - S93
12345